SpO2 Validation Study - Philips FAST 2024

Completed

Conditions studied: Pulse Oximetry

In brief

Validation study to compare the accuracy of non-invasive Philips SpO2 sensors in detecting blood oxygen levels compared to invasive methods requiring a blood draw and lab analysis.

Key facts

Study ID

NCT06484452

Run by

Philips Clinical & Medical Affairs Global

People needed

113

Starts

2024-05-06

Expected to finish

2024-08-29

Last updated by the study team

2025-09-16

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participant must have the ability to understand and provide written informed consent
• Participant is adult between 18-50 years of age
• Participant must be willing and able to comply with study procedures and duration
• Participant is a non-smoker or who has not smoked within 2 days prior to the study.

You may not qualify if…

• Participant is considered as being morbidly obese (defined as BMI >39.5)
• Participants with compromised circulation (i.e., Raynaud's Syndrome), injury, or physical malformation of fingers, toes, hands, ears, nose, forehead/skull, or other sensor sites which would limit the ability to test sites needed for the study. Tattoo (e.g. permanent, Henna) or artificial dyes (including spray tan, pigmented tanning lotion) in the optical path which would limit the ability to test sites needed for the study. (Note: Certain malformations may still allow participants to participate if the condition is noted and would not affect the particular sites utilized.)
• Females who are pregnant, who are trying to get pregnant, (confirmed by positive urine pregnancy test unless the participant is known to be not of child-bearing potential)
• Participants who have smoked in the last 2 days or participants who have refrained, for at least 48 hours, with COHb levels >3% as assessed with a Masimo Radical 7 (Rainbow)
• Participants with known respiratory conditions such as: (self-reported)
• uncontrolled / severe asthma,
• flu,
• pneumonia / bronchitis,
• shortness of breath / respiratory distress,
• unresolved respiratory or lung surgery,
• emphysema, COPD, lung disease,
• Recent COVID (last 2 months)
• Participants with self-reported heart or cardiovascular conditions such as: (self-reported, except for blood pressure and ECG review)
• high blood pressure: systolic >140 mmHg or diastolic >90 mmHg on 3 consecutive readings (reviewed during health screen),
• have had cardiovascular surgery, except successful minor surgery without clinical symptoms (i.e., PFO, PDA),
• chest pain (angina),
• heart rhythms other than a normal sinus rhythm or with respiratory sinus arrhythmia (reviewed during health screen),
• previous heart attack,
• blocked artery,
• unexplained shortness of breath,
• congestive heart failure (CHF),
• history of stroke,
• transient ischemic attack,
• carotid artery disease,
• myocardial ischemia,

Where it is running

• Element Materials Technology — Louisville, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.